VRTX

VRTX Operating Income Growth

24.17%TTM

Period ending:

VRTX TTM Operating Income YoY %%
VRTX TTM Operating Income YoY %9463.39%-44016.51%
1991-12-312026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

VRTX operating income growth history

Year-over-year operating income growth rate. The available trailing twelve months (ttm) series contains 139 observations from Dec 31, 1991 to Jun 30, 2026.

Vertex Pharmaceuticals Operating Income Growth — Trailing twelve months (TTM)
Period endingOperating Income Growth
24.1748%
743.3787%
1,932.4603%
1,576.8491%
1,225.502%
-117.7054%
-106.0778%
-106.9745%
-108.7906%
3.6337%
-11.0368%
-6.6143%
-2.7899%
37.8265%
54.8234%
56.6506%
79.8715%
-2.9326%
-2.5961%
-0.4408%
8.5639%
84.2733%
138.5079%
244.0015%
137.3551%
109.561%
88.5485%
22.2151%
767.3627%
4,287.9185%
415.364%
1,604.5308%
-70.2828%
-106.4011%
1,676.8599%
142.1199%
350.1736%
193.9233%
101.48%
84.4405%
78.6393%
52.053%
32.377%
30.3333%
20.6676%
4.8263%
23.2876%
-15.116%
-40.3778%
-29.1764%
-38,841.0377%
-332.7072%
-210.2365%
-244.4037%
-97.9512%
209.7551%
175.2138%
152.5185%
116.3516%
59.0755%
-10.756%
-13.6011%
-13.3654%
-10.9998%
-5.6218%
-16.4559%
-32.6997%
-47.6409%
-49.4722%
-22.3229%
-10.2232%
-13.6692%
-27.1277%
-62.2805%
-83.2849%
-64.6162%
-54.9927%
-65.3338%
-52.8224%
-34.5212%
-27.9154%
0.2683%
3.1878%
26.7738%
42.59%
49.8381%
41.4778%
-18.6153%
-96.322%
-330.8616%
-121.169%
-85.9931%
-36.8984%
21.9072%
-41.5097%
-21.6638%
-63.0447%
-168.0144%
-118.4996%
-275.984%

Compare operating income growth

All VRTX financial metrics · VRTX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.